USANA Health Sciences (USNA) Misses Q4 EPS by 16c; Issues Light FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
USANA Health Sciences Reports Fourth Quarter and Full-Year Financial Results
February 9, 2016 4:17 PM ESTFourth quarter net sales increased by 2.1% to $232.6 million, but increased by 17.7% excluding the impact of a stronger U.S. dollar and a shorter 13-week reporting period Fourth quarter EPS increased by 10.9% to $1.83 Number of active Associates increased by 20.6% to 421,000 For the year, net sales increased by 16.2% to a record $918.5 million and EPS increased by 28.2% to a record $7.18 Initial 2016 net sales and earnings outlook provided
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE:... More
